Systemic effects from retatrutide's mechanism: Based on the GLP-1/GIP/glucagon receptor class, potential adverse effects include nausea, vomiting, diarrhoea, reduced appetite, and gastrointestinal disturbance
Quick Answer: Wegovy and lisdexamfetamine can be prescribed together for their respective licensed indications, but require careful clinical assessment and close monitoring due to overlapping effects on appetite, cardiovascular parameters, and gastrointestinal function
The release of the carrier loaded with 6MP for 7 days has no application potential for intravenous administration due to its removal after less than 24 h
Their average weight decreased from 87.9 kg before treatment to 74.1 kg during the weekly injection phase, and further decreased slightly to 72.4 kg after extending the interval
Tambin puede ir directamente al sitio web del fabricante e ingresar su informacin para determinar si tiene cobertura